Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 14 September, 2018

Societe Generale SA

Stabilisation Notice - IPSOS

RNS Number : 8601A
Societe Generale SA
14 September 2018
 

Date: 14/09/2018

Not for the distribution, directly or indirectly in to the United States or any jurisdiction in which such distribution would be unlawful.

IPSOS - Stabilisation Notice

Societe Generale (Contact: RONAN MURPHY;  telephone:  +44-20-7676-7463) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The Securities:

 

Issuer:

IPSOS

Guarantor (if any):

N/A

Aggregate Nominal Amount:

EUR 300M no grow

Description:

SENIOR UNSECURED, 2.875% FIXED ANNUAL, DUE SEP 2025

Offer price:

99.184

Stabilisation:

 

Stabilising managers:

SG CIB

Stabilisation Period expected to start on:

14/09/2018

Stabilisation period expected to end no later than:

19/10/2018

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager(s) may over-allot the securities to the extent permitted in accordance with SG's Policy.

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any Stabilising action and any Stabilising action, if begun, may be ended at any time. Any Stabilising action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STAGMGMLFDFGRZM

a d v e r t i s e m e n t